Biopharma

FDA Clarifies Policies for Compounders as National GLP-1 Supply Begins to Stabilize

FDA Clarifies Policies for Compounders as National GLP-...

Feb 9, 2025 0

Audience: Industry October 2, 2024 -- The U.S. Food and Drug Administration has ...

Public Safety Notification on Amniotic Fluid Eyedrops

Public Safety Notification on Amniotic Fluid Eyedrops

Feb 9, 2025 0

Audience: Patients, Health Care Practitioners October 17, 2024 Update: In August...

C&A Naturistics Issues Voluntary Nationwide Recall of AK Forte Tablets con Ortiga y Omega 3 Due to the Presence of Undeclared Drug Ingredients

C&A Naturistics Issues Voluntary Nationwide Recall of A...

Feb 9, 2025 0

Audience: Consumers October 16, 2024 – National City, CA, C&A Naturistics is vol...

FDA Warns Patients and Health Care Professionals Not to Use Compounded Drugs from Fullerton Wellness

FDA Warns Patients and Health Care Professionals Not to...

Feb 9, 2025 0

Audience: Patients, Health Care Professionals November 1, 2024 -- FDA is warning...

Do Not Purchase or Use Skin-Cap Aerosol Spray Products Because They May Be Harmful to Your Health

Do Not Purchase or Use Skin-Cap Aerosol Spray Products ...

Feb 9, 2025 0

Audience: Consumers October 30, 2024 -- FDA is warning consumers to not purchase...

VitalityVita Issues Voluntary Nationwide Recall of VitalityXtra and PeakMax Capsules Due to the Presence of Undeclared Sildenafil and Diclofenac

VitalityVita Issues Voluntary Nationwide Recall of Vita...

Feb 9, 2025 0

Audience: Consumers November 4, 2024 – Sacramento, CA, VitalityVita.com is volun...

Boulla LLC Issues Voluntary Nationwide Recall of ZoomMax and ZapMax Capsules Due to the Presence of Undeclared Sildenafil and Diclofenac

Boulla LLC Issues Voluntary Nationwide Recall of ZoomMa...

Feb 9, 2025 0

Audience: Consumers November 4, 2024 – Sacramento, CA, Boulla LLC is voluntarily...

Endo Expands Voluntary Recall of Clonazepam Orally Disintegrating Tablets, USP (C-IV) Due to Potential Product Carton Strength Mislabeling

Endo Expands Voluntary Recall of Clonazepam Orally Disi...

Feb 9, 2025 0

Audience: Healthcare Provider, Pharmacy, Consumer November 19, 2024 -- Endo, Inc...

FDA Investigating Serious Risk of Hematologic Malignancy Following Skysona (elivaldogene autotemcel)

FDA Investigating Serious Risk of Hematologic Malignanc...

Feb 9, 2025 0

Audience: Health Professional November 27, 2024 -- Since approval, the Food and ...

Mxbbb Issues Voluntary Nationwide Recall of Umary Acid Hyaluronic Due to the Presence of Diclofenac and Omeprazole

Mxbbb Issues Voluntary Nationwide Recall of Umary Acid ...

Feb 9, 2025 0

Audience: Healthcare Provider, Pharmacy, Consumer November 20, 2024 -- MXBBB is ...

Buy-herbal.com Issues Voluntary Nationwide Recall of Nhan Sam Tuyet Lien Truy Phong Hoan Capsules Due to Undeclared Furosemide, Dexamethasone and Chlorpheniramine

Buy-herbal.com Issues Voluntary Nationwide Recall of Nh...

Feb 9, 2025 0

Audience: Consumer Flushing, New York, Buy-herbal.com is voluntarily recalling a...

FDA Adds Boxed Warning to Veozah (fezolinetant) to Highlight the Known Risk of Rare But Serious Liver Injury

FDA Adds Boxed Warning to Veozah (fezolinetant) to High...

Feb 9, 2025 0

Audience: Patient, Health Professional, OBGYN, Endocrinology Update: December 16...

Drug Safety Communication: Ocaliva (obeticholic acid) - Serious Liver Injury Being Observed in Patients without Cirrhosis

Drug Safety Communication: Ocaliva (obeticholic acid) -...

Feb 9, 2025 0

Audience: Gastroenterology, Hepatology, Patient, Health Care Professional, Pharm...

Endo USA, Inc. Issues Voluntary, Nationwide Recall of Adrenalin® Chloride Solution (EPINEPHrine Nasal Solution, USP) Due to the Potential for Administration Errors

Endo USA, Inc. Issues Voluntary, Nationwide Recall of A...

Feb 9, 2025 0

Audience: Healthcare Professional, Pharmacy, Consumer MALVERN, PA, December 20, ...

Shoppers-Plaza Issues Voluntary Nationwide Recall of Fouzee Sugarlin Herbal Formula Due To Presence Of Undeclared Metformin And Glyburide

Shoppers-Plaza Issues Voluntary Nationwide Recall of Fo...

Feb 9, 2025 0

Audience: Consumer December 16, 2024 – Los Angeles, California - Shoppers-Plaza ...

Astellas Issues Recall of One Lot of Prograf 0.5 mg and One Lot of Astagraf XL 0.5 mg Because Bottles Shipped to U.S. May Contain Empty Capsules

Astellas Issues Recall of One Lot of Prograf 0.5 mg and...

Feb 9, 2025 0

Audience: Healthcare Provider, Pharmacy, Consumer NORTHBROOK, IL, Dec. 23, 2024 ...

Alcon Laboratories Issues Voluntary Nationwide Recall of One Lot of Systane Lubricant Eye Drops Ultra PF Due to Fungal Contamination

Alcon Laboratories Issues Voluntary Nationwide Recall o...

Feb 9, 2025 0

Audience: Healthcare Provider, Pharmacy, Consumer December 21, 2024 – Fort Worth...

FDA Warns Health Care Professionals Not to Use Epinephrine Nasal Solutions from BPI Labs and Endo USA

FDA Warns Health Care Professionals Not to Use Epinephr...

Feb 9, 2025 0

Audience: Health Care Professionals January 16, 2025 -- FDA is warning health ca...

FDA Requires Guillain-Barré Syndrome (GBS) Warning in the Prescribing Information for RSV Vaccines Abrysvo and Arexvy

FDA Requires Guillain-Barré Syndrome (GBS) Warning in t...

Feb 9, 2025 0

Audience: Patient, Health Care Professional, Pharmacy, Immunology, Pulmonology I...

Provepharm Inc. Issues Recall of One Lot of Phenylephrine Hydrochloride Injection, USP, 10 mg/ mL (Pharmacy Bulk Package) Due to Presence of Particulate Matter

Provepharm Inc. Issues Recall of One Lot of Phenylephri...

Feb 9, 2025 0

Audience: Pharmacy, Consumer January 24, 2025 – Collegeville, Pennsylvania, Prov...

Drug Safety Communication: Copaxone, Glatopa (glatiramer acetate) - FDA Adds Boxed Warning About a Rare but Serious Allergic Reaction Called Anaphylaxis

Drug Safety Communication: Copaxone, Glatopa (glatirame...

Feb 9, 2025 0

Audience: Patient, Caregiver, Health Care Professional, Pharmacy, Neurology ISSU...

Alvogen Issues Voluntary Nationwide Recall for One Lot of Fentanyl Transdermal System 25 mcg/h Due to a Defective Delivery System

Alvogen Issues Voluntary Nationwide Recall for One Lot ...

Feb 9, 2025 0

Audience: Consumer, Health Professional, Pharmacy January 31, 2025 – Morristown,...

Genentech’s Phase IIb Study of Prasinezumab Missed Primary Endpoint, but Suggests Possible Benefit in Early-Stage Parkinson’s Disease

Genentech’s Phase IIb Study of Prasinezumab Missed Prim...

Feb 9, 2025 0

South San Francisco, CA -- December 18, 2024 -- Genentech, a member of the Roche...

Pila Pharma Announces XEN-D0501 Preclinical Proof-of-Concept Achieved In Cardiovascular Disease Study

Pila Pharma Announces XEN-D0501 Preclinical Proof-of-Co...

Feb 9, 2025 0

Malmö, Sweden 18 December 2024 PILA PHARMA AB (publ) (“PILA PHARMA” or the “Comp...

65
66
67
68
69

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.